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The pathogenesis remains unknown, but infection may be a trigger in a genetically susceptible host. Elevated levels of cytokines including interleukin-1, interleukin-6, and tumor necrosis factor alpha (TNF-a) may play a key role in the induction and development of AOSD. 2 Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease affecting the small intestine and colon. Multiple pathogenic factors including environmental, genetic, and gut microbiota interact with the immune system, leading to a dysregulated immune response, resulting in chronic intestinal inflammation. 3 Inflammatory bowel disease is an extra-articular manifestation in rheumatic diseases such as spondyloarthropathies, but only a few cases on concurrent AOSD and IBD, mainly CD, have been reported. In this report, we describe the first case of UC diagnosed during the treatment of AOSD.
CASE REPORT
A 37-year-old male patient was admitted for a seven-day history of fever above 39 °C. He complained of headache, sore throat, and symmetric arthralgia of the shoulders and knees. Physical examination showed a salmon-colored macular rash on his abdomen and chest. Laboratory analysis revealed a white blood cell count of 27,000 cells/mm Antinuclear antibody, rheumatoid factor, and anti-cyclic citrullinated peptide antibody were all absent. Extensive evaluation to identify the cause of the fever revealed no evidence of infection or malignancy. However, his findings were indicative of AOSD. He complied with three major Yamaguchi criteria 4 fever, arthralgia, and leukocytosis-and several minor criteria including sore throat, negative rheumatoid factor and fluorescent antinuclear antibody test results, and abnormal liver function tests; these were also indicative of the diagnosis of AOSD. He was treated with nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids (0.5 mg/kg/day), with symptom resolution and normalization of biochemical markers. After reduction of the steroids over a six-month period with concomitant administration of methotrexate (12.5 mg/week) and NSAIDs, the AOSD remained stable without relapse. After one year, he complained of abdominal pain, diarrhea, and frequent passage of bloodstained stool. Upon physical examination, mild tenderness was elicited in the peri-umbilical region. Laboratory evaluation was significant only for a hemoglobin level of 11 g/dL. The patient underwent endoscopic and colonoscopic examination with the presumptive diagnosis of NSAID-induced gastropathy. Unexpectedly, diffuse erosion with edema and erythema, and multiple shallow ulcers were detected in the sigmoid colon and rectum by colonoscopy (Figure 1) . The mucosal biopsy specimens revealed glandular distortion and cryptitis with crypt abscess (Figure 2 ), which were compatible with UC. After establishing the diagnosis of UC, he was treated with hydrocortisone and mesalazine. His symptoms of colitis began to improve after two weeks of treatment.
DISCUSSION
Adult-onset Still's disease presents with heterogeneous manifestations. However, no cases on the coexistence of AOSD and UC have been reported to date, whereas CD with AOSD is occasionally reported. The mechanisms underlying the intestinal-related presentation of AOSD remain obscure, but various data supporting the association between arthritis and IBD have been reported. For example, a study including 792 patients with IBD revealed that a considerable portion of those with CD (20.2%) and UC (11.0%) present with arthritis. 5 In a study in Finland, pediatric-onset IBD patients showed a higher frequency of arthritis compared with the control group (5.4% versus 0.2%). 6 Furthermore, in an analysis of patients with juvenile idiopathic arthritis (JIA), 81% of the patients showed abnormal findings that were classified as active chronic or CD-like lesions on ileocolonoscopy. 7 Additionally, the polymorphisms for JIA have been shown to share with those of other autoimmune diseases including CD in the genome-wide association studies. 8 AOSD follows the same continuum as systemic-onset JIA, so it is regarded as a subtype of JIA. In addition, recent studies suggest that AOSD has two distinct subsets: one with prominent systemic features and the other with chronic arthritis associated with TNF-a. 9 In light of this, AOSD, as a subtype of JIA or arthritis, could exhibit IBD as an extra-articular manifestation. This may be the supporting evidence for the unusual cases of coexistence of AOSD and IBD. Anti-TNF-a antibodies have been used in the treatment of both AOSD and refractory IBD, because TNF-a is implicated in the pathogenesis of both of them. Considering this information, it is plausible that IBD could be present concurrently with AOSD as an extra-articular manifestation.
It is known that inflammatory-related extraintestinal manifestations are more common in CD than in UC and a more vigorous response and increased T cell function occur in CD than in UC. However, since both CD and UC share multiple pathologic factors including environmental changes, abnormal gut microbiota, and a wide aberrant immune response, 3 it is possible to see the coexistence of AOSD and UC, as in our case.
Diagnosis of AOSD is challenging for the clinicians. It presents diverse manifestations that are not disease specific; clinicians need to exclude neoplastic, infectious, or inflammatory disorders first. After establishing the diagnosis, heterogeneous manifestations are not easily distinguishable, whether originating from the AOSD or other complications. For example, when patients with AOSD complain of abdominal discomfort, they are likely to have a presumptive diagnosis of NSAID-induced gastropathy because the treatment of AOSD has centered on the use of NSAIDs. However, as seen in our case, UC may be a causative factor for abdominal pain, so the routine empirical treatment without detailed investigation may aggravate the disease. Accordingly, we believe that patients' personal history and laboratory and endoscopic evaluation results may provide the exact and timely diagnosis and management of UC combined with AOSD.
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